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Abstract
We describe a novel basic leucine zipper transcription factor, XXBP-1, which interacts with BMP-4 in a positive feedback loop. It is
a maternal factor and is zygotically expressed in the dorsal blastopore lip and ventral ectoderm with the exception of the prospective neural
plate during gastrulation. Overexpression of XXBP-1 leads to ventralization of early embryos as described for BMP-4, and inhibits
neuralization of dissociated ectoderm. Consistent with mediating BMP signaling, we show that the ectopic expression of XXBP-1 recovers
the expression of epidermal keratin and reverses the dorsalization imposed by truncated BMP receptor type I, indicating that it may act
downstream of the BMP receptor. Its effects can be partially mimicked by a fusion construct containing the VP16 activator domain and the
XXBP-1 DNA-binding domain. In contrast, fusing the DNA-binding domain to the even-skipped repressor domain leads to upregulation
of the neural markers NCAM and nrp-1 in animal cap assay. Taken together, the results suggest a role for XXBP-1 in the control of neural
differentiation, possibly as an activator.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Embryonic development requires differential temporal
and spatial gene expression as well as cell-to-cell interac-
tions, including embryonic induction. In Xenopus, antero-
posterior and dorsoventral pattern formation depends in part
on the interaction of dorsalizing genes and bone morpho-
genetic proteins (BMPs)1 (Grunz and Tacke, 1989, 1990;
Wilson and Hemmati-Brivanlou, 1995; for review, see
Weinstein and Hemmati-Brivanlou, 1997). Disruption of
the BMP feedback loop in ectoderm initiates the process of
neural induction, resulting in the suppression of epidermal-
specific genes and the activation of regulatory and structural
genes specific for neural tissues (Weinstein and Hemmati-
Brivanlou, 1997; Hemmati-Brivanlou and Melton, 1997).
During gastrulation, dorsalizing factors such as noggin
(Zimmerman et al., 1996), Xnr3 (Smith et al., 1995), Chor-
din (Sasai et al., 1995), follistatin (Fainsod et al., 1997),
Cerberus (Piccolo et al., 1999), and Dickkopf 1 (Glinka et
al., 1998) antagonize extracellular BMPs by preventing
their interaction with cognate BMP receptors. In the absence
of organizer signals, ectoderm differentiates into epidermis
and ventral mesoderm, due in part to the activity of BMPs
(Kno¨chel et al., 1987; Ko¨ster et al., 1991; Plessow et al.,
1991).
In addition to their role as negative regulators of neural
induction, BMPs act as morphogens in dorsoventral meso-
derm patterning. At least four mesoderm-related territories
can be defined in early gastrula stages: (1) the organizer
area, expressing genes such as goosecoid, Xnot, Chordin,
and noggin; (2) a dorsolateral territory, expressing genes
such as Xmyf5 and Xvent-2; (3) a ventrolateral territory,
marked by the expression of Xvent-1 and Xvent-2; and (4) a
ventral territory coexpressing Xvent-1, Xvent-2, and sizzled
(Dale and Jones, 1999). The expression of these genes is
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regulated by BMP-4 in a dose-dependent manner, resulting
in three domains of the marginal zone (Dosch et al., 1997).
Overexpression of BMP-2, -4, and -7 leads to ventralization
of early mesoderm (Dale and Jones, 1999). Blocking
BMP-4 signaling in the ventral part of the Xenopus embryo
prevents blood formation and induces formation of a sec-
ondary dorsal axis (for review, see Graff, 1997).
Besides their involvement in ventral mesoderm forma-
tion and neural fate repression, BMPs also play an essential
role in limb and tooth development and regulation of apo-
ptosis. The different effects depend on which intracellular
cofactors participate in BMP signaling and crosstalk be-
tween BMP signaling and other signaling pathways (for
review, see von Bubnoff and Cho, 2001). BMPs as well as
other members of the transforming growth factor  family
utilize the signal transduction cascade mediated by the
Smad family of proteins (Massague´, 1996). In Xenopus
embryos, Smad1 and Smad5 can mimic many BMP func-
tions and activate BMP-inducible genes (Graff et al., 1996;
Suzuki et al., 1997; Henningfeld et al., 2000), while over-
expression of Smad8 phenocopies the effect of blocking
BMP-4 signaling, leading to the induction of a secondary
axis on the ventral side of intact embryos and to direct
neural induction in ectodermal explants (Nakayama et al.,
1998).
There is abundant evidence that a large number of genes
are involved in BMP signaling in different cell types and
tissues. In this study, we present data that Xenopus X-box
binding protein 1 (XXBP-1), a basic leucine zipper tran-
scription factor, is involved in the BMP signaling pathway.
Overexpression of XXBP-1 leads to ventralization of early
embryos as does BMP-4. In addition, ectopic XXBP-1 can
inhibit neural induction and dorsalization imposed by dom-
inant negative BMP receptor type I (tBMPRI). These results
indicate that XXBP-1 mediates epidermal induction as well
as inhibition of neural differentiation in the BMP signaling
pathway downstream of the BMP receptor. Moreover, we
suggest that XXBP-1 functions as a transcription activator
involved in the repression of neural fate.
Materials and methods
Embryo manipulations
In vitro fertilization was carried out as previously de-
scribed (Zhao et al., 2001). Embryos were staged according
to Nieuwkoop and Faber, (1975). For UV treatment, fertil-
ized eggs were dejellied thoroughly approximate 20 min
after insemination, then immediately transferred to Petrip-
erm petri dishes with a UV-permeable bottom (Heraeus,
Hanau, DE) and treated with a UV transilluminator for 45 s.
Eggs were left undisturbed at room temperature for 2 h or at
least until the first cleavage. Animal caps were dissected
from stage 9 embryos in Holtfreter’s solution and cultured
in 1  Barth’s solution until intact embryos from the same
batch reached the desired stages. Dorsal and ventral mar-
ginal zones (DMZs and VMZs) were isolated at stage 10-
10.5. DMZs corresponded to a 60° arc of marginal zone
tissue centered at the dorsal lip midline. VMZs were cut
analogously from the region opposite the DMZs and then
were cultured in 1  Barth’s solution until the desired
stages. The dissociation procedure was described elsewhere
in detail (Grunz, 1969; Grunz and Tacke, 1989). Briefly, the
animal caps dissected at stage 9 were disaggregated in
Ca2/Mg2-free Barth’s solution by gently pipetting with a
Pasteur pipette in an agar-coated petri dish. The single cells
were kept in Ca2/Mg2-free Barth’s solution for 1 h,
followed by normal Barth’s solution for 3 h, then were
reaggreagated. The reaggregates were harvested for RT-
PCR analysis after culture at room temperature overnight.
Constructs
A ZAP Express phage cDNA library constructed from
activin-treated ectoderm was screened by using large-scale
whole-mount in situ hybridization. XXBP-1 was selected
from several interesting clones for further functional study.
The coding region was subcloned into pCS2 (Turner et
al., 1994) for microinjection. The DDBJ/EMBL/GenBank
Accession No. of XXBP-1 is AF358133.
To construct XXBP1-VP16, the sequence encoding the
VP16 activation domain was fused with the sequence en-
coding the first 126 amino acids of XXBP-1 containing the
basic leucine zipper domain (bZIP; see Fig. 6I). The bZIP
domain is thought to be responsible for the dimerization and
DNA binding in leucine zipper transcription factors (Lewin,
2000). The VP16 activation domain sequence (VP16, 261
bp; Friedman et al., 1988) was amplified from the VPX-
vent-1 plasmid (Onichtchouk et al., 1998) via PCR using the
pfu DNA polymerase and the primers: 5 -phosphorylated
VP16 forward, GACTCCCAGCAGCC and VP16 reverse,
GCGCTCTAGATTAGTCAATTCCAAGGGCATCGGT
(XbaI site and the stop codon are in boldface). The amplified
products were digested with XbaI and gel purified. The bZIP
sequence of XXBP-1 (encoding the N-terminal 126 amino
acids) was amplified from the pCS2-XXBP-1 plasmid via
PCR using pfu DNA polymerase and the primers: XXBP-1
forward, GCGCGAATTCAATGGTGGTCGTGGGAGCC
(EcoRI cutting site in boldface) and 5-phosphorylated delta
XBP reverse, TAGGCCCAATCTTTGGCG. The amplified
products were digested with EcoRI and gel purified. Both
the VP16 and bZIP fragments were cloned into the EcoRI–
XbaI-digested pCS2 to produce XXBP1-VP16. Similarly,
the sequence encoding the even-skipped repression domain
(Han and Manley, 1993) was fused to the XXBP-1 bZIP
sequence to create XXBP1-Eve. The even-skipped repres-
sion domain sequence (Eve, 777 bp) was amplified from
EveXvent-1 (Onichtchouk et al., 1998) using the primers: 5
-phosphorylated Eve forward, AGCACGATCAAGGT-
GTGG and Eve Reverse, GCGCTCTAGATTACGCCT-
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CAGTCTTGTAGGG (XbaI site and the stop codon are in
boldface).
The sequence encoding the first 126 amino acids of
XXBP-1 containing the bZIP region with a stop codon at the
3 end was subcloned into pCS2 to yield truncated
XXBP-1. Additionally, this fragment was also cloned into
pCS2MTEnR without the stop codon to obtain XBP-EnR
with the Drosophila engrailed repressor domain at the car-
boxyl terminus and an N-terminal myc-tag.
LacZ staining and whole-mount in situ hybridization
LacZ staining was carried out as described previously
(Zhao et al., 2001). Whole-mount in situ hybridization
was performed as described elsewhere (Harland, 1991;
Oschwald et al., 1991).
Microinjection experiments
Capped mRNAs were synthesized from linearized plas-
mids in vitro by using the Cap Scribe kit (Roche). Dejelled
embryos were microinjected in 4% Ficoll 400 dissolved in
1  Barth’s solution. Embryos were injected at the two-cell
or four-cell stages, then kept in the same solution for 1 h
subsequently. Injected embryos were transfered to Holt-
freter’s solution for further development. Dorsal and ventral
regions of the embryos were identified by pigment varia-
tions and size of the blastomeres. Radial injection refers to
the microinjection of all four blastomeres of four-cell-stage
embryos into the equatorial region. Morpholino injection
was carried out as described by Heasman (Heasman et al.,
2000).
RT-PCR
RT-PCR assays were carried out as described previously
(Zhao et al., 2001). Gene-specific primers were as follows:
Otx2, BMP-4, NCAM, XAG1, Epidermal Keratin, Xbra
from the Web site (http://www.hhmi.ucla.edu/derobertis/
index.html); Xhox3 (Ruiz i Altaba and Melton, 1989);
Xvent-1 (Gawantka et al., 1995); gsc (Blumberg et al.,
1991); Xnot-1 (von Dassow et al., 1993); Muscle actin
(Mohun et al., 1984); Xnrp-1 (Richter et al., 1990); Msx1
(Su et al., 1991); XXBP-1 Reverse: TCACTTGCTGTTC-
CAGTTCA, XXBP-1 Forward: GCCCCCAAAGT-
GATCTTTAT. Each experiment was carried out at least
three times with similar results.
Histology
Standard techniques were used to prepare histological
sections as described elsewhere (Grunz, 1977, 1983). After
whole-mount in situ hybridization, embryos were embedded
into paraffin. Sections (12 m) were counterstained with
eosine (Penzel et al., 1997).
Results
XXBP-1 is a novel basic leucine zipper transcription
factor
The cDNA sequence of the XXBP-1 (GenBank Acces-
sion No. AF358133) revealed an open reading frame en-
coding a polypeptide of 350 amino acids. Between amino
acids 85 and 120 of the protein, there is a hypothetical
leucine zipper sequence characteristic of basic leucine zip-
per (bZIP) transcription factors, in which seven residue
spacers separate two leucines. A basic region rich in argi-
nine and lysine (amino acid 46–81; Fig. 1) is NH2-terminal
to the leucine zipper. The predicated amino acid sequence is
most similar to human X-box binding protein 1 (hXBP-1;
Accession No. NM_005080, 66% amino acid identity; Liou
et al., 1990), rat XBP-1 (Accession No. JC4857, 66% amino
acid identity), mouse XBP-1 (Accession No. NP_038870,
66% amino acid identity), and zebrafish Treb5 (Accession
No. AY029577, 59% amino acid identity, Liang et al.,
2001) as shown in Fig. 1. Although the Xenopus sequence
outside the bZIP domain is more divergent as compared
with the rat, mouse, human, and zebrafish, it shares high
amino acid identity within the bZIP domain (88% amino
acid identity to human, 86.7% to mouse, 86.7% to rat,
77.3% to zebrafish). Therefore, it is likely to be the Xenopus
homologue and was named Xenopus X-box binding protein
1 (XXBP-1).
Expression pattern of XXBP-1
In whole-mount in situ hybridization (Fig. 2I), XXBP-1
expression was first detectable faintly in the animal half
prior to gastrulation. Expression increased particularly in
the dorsal blastopore lip at onset of gastrulation (Fig. 2I:
D1–D3 for stage 10, E1–E3 for stage 11; Nieuwkoop and
Faber, 1975). Additionally, XXBP-1 was expressed to a
lesser extent in the entire ventral marginal zone and animal
half. As gastrulation progressed, staining was detected as a
short dorsal stripe beginning at the blastopore; however, the
prospective neural plate was devoid of staining, and strong
staining of the ventral area was observed (Fig. 2I: F1–F3 for
stage 11.5, G1–G3 for stage 12, H1–H3 for the stage 12.5).
At stage 15, XXBP-1 was strongly expressed in the area
anterior to the neural plate corresponding to the cement
gland primordium (Fig. 2I: I–K). This expression pattern is
reminiscent of BMP-4, whose expression is maximal in the
cement gland primordium at this stage. To a lesser extent,
XXBP-1 was expressed in a stripe starting from the slit-like
blastopore at the midline of the neural plate that corresponds
to the notochord (Fig. 2IIC and C1). In the late neurula and
early tailbud stages, intense staining was observed in the
cement gland with two faint extensions to the hatching
gland (Fig. 2IL and M). Another area of XXBP-1 expression
extended from the cement gland to the ventral side as shown
in Fig. 2IM and N. Although there is evidence that human
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XBP-1 plays an important role in fetal liver development
(Reimold et al., 2000), the XXBP-1 expression zone did not
correspond to the liver primordium (Fig. 2IIB and B1). In
tailbud and tadpole stages, expression was observed in the
cement gland, pronephros, ear vesicle, and the upper part of
the lens (Fig. 2I: O–R; Fig. 2IID).
The temporal expression of XXBP-1 indicates that
XXBP-1 is a maternal factor which is weakly expressed
before gastrulation, then upregulated during gastrulation
and maintained in the following stages (Fig. 2IIIA). Fur-
thermore, XXBP-1 was ubiquitously expressed in the adult
tissues examined with the highest expression levels in liver,
lung, and stomach (Fig. 2IIIB).
Effects of neural inhibitors and neural inducers on the
expression of XXBP-1
The absence of XXBP-1 expression in the prospective
neural plate during gastrulation indicates that it may be a
negative control factor of neural induction. In respect to
both ventralizing and epidermalizing effects on XXBP-1, we
investigated the effects of anti-neural factors such as
BMP-4, UV irradiation, Msx1, and Dlx3 on the expression
of XXBP-1 by whole-mount in situ hybridization. In addi-
tion, we used a -catenin morpholino (MO) as an inhibitor
of the Wnt/-catenin pathway to study the expression of
XXBP-1 regulated by the Wnt/-catenin signaling pathway.
Both dorsal blastomeres of four-cell-stage embryos were
injected with -catenin MO (8 ng/embryo), BMP-4 (1 ng/
embryo), Dlx3 (80 pg/embryo), or Msx1 (80 pg/embryo)
mRNA. Whole-mount in situ hybridization with XXBP-1
antisense RNA was performed on the injected embryos at
midgastrula (stage 11-12). Overexpression of any of these
factors expanded the expression territory of XXBP-1 on the
dorsal side of the embryos (Fig. 3I). XXBP-1 was activated
in the dorsal as well as ventral marginal zones after injection
of BMP-4 mRNA (98%, 42/43 embryos) or -catenin MO
(100%, 73/73 embryos) and in UV-treated embryos (100%
23/23 embryos). XXBP-1 was expressed to a lesser extent
after overexpression of either Msx1 (70%, 16/23 embryos)
or Dlx3 (100%, 29/29 embryos). The overexpression of
Msx1 or Dlx3 expanded the expression of XXBP-1 into the
prospective neural plate area. These results indicate that the
area where XXBP-1 is expressed can be increased by neural
inhibitors. Moreover, XXBP-1 may also be negatively reg-
ulated by the Wnt/-catenin pathway since blockage by the
Fig. 1. The alignment of XXBP-1 and its homologues in human, mouse, rat, and zebrafish. The putative bZIP domain is underlined. Black boxes indicate
conserved amino acids, and gray boxes indicate similar amino acids. Dashes represent gaps introduced into the sequence to obtain optimal alignment. The
GenBank Accession No. for XXBP-1 is AF358133.
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Fig. 2. Expression of XXBP-1. (I) Spatial expression pattern of XXBP-1. Whole-mount in situ hybridization for XXBP-1 at several stages of Xenopus early
development is shown from different views (dorsal–lateral, dor-lat; vegetal, veg; ventral, ven). (A–C) XXBP-1 is faintly expressed in the animal half at early cleavage
stages. (D, E) At the start of gastrulation, XXBP-1 becomes concentrated at the dorsal blastopore lip and is strong in the ventral ectoderm. (F–H) As gastrulation
progresses, expression stretches anteriorly from the blastopore, and ventral expression is maintained. (I– K) In the neurula, expression is concentrated in the area
anterior to the neural plate (the prospective cement gland) and notochord. Expression also stretches posteriorly along the neural crest in a gradient. (L–N) At stage
19–20, expression is strong in the cement gland, weaker posteriorly in the hatching gland, and in a ventral midline stripe. (O–R) Later stages show expression in
the cement gland, pronephros (primarily glomus), ear vesicle, and the upper part of the lens. (II) Histological analysis of XXBP-1 expression. (A) A transverse section
through a stage 12 embryo shows expression in the ventral ectoderm (ed) and dorsal blastopore lip (bl, higher magnified in A1). (B) A sagittal section through a
stage 18 embryo shows expression in the cement gland (cg) and some ventral mesodermal cells adjacent to ectoderm (arrow, higher magnified in B1). (C) A
transverse section through the posterior end of a stage 17 embryo shows expression in the notochord (nc). (C1) Higher magnification of the notochord from (C). (D)
A transverse section through a stage 28 embryo shows expression in pronephros (pn). ac, archenteron; bt, blastocoel; en, endoderm; sc, spinal cord; sm, somite. (III)
Expression of XXBP-1 in developing embryos and adults tissues. RT-PCR was performed on total RNA extracted from embryos at the different, indicated embryonic
stages (A) or adult tissues (B). Ornithine decarboxylase (ODC) and histone 4A (H4) were used as loading controls. XXBP-1 is a maternal factor which is weakly
expressed before gastrulation, upregulated during gastrulation, and maintained in following stages. XXBP-1 was detected in all adult tissues tested, with higher
expression levels in liver, lung, and stomach. br, brain; ey, eye; he, heart; in, intestine; ki, kidney; li, liver, lu, lung; mu, muscle; ne, nerve; ov, ovary; sp, spleen;
st, stomach; te, testis; RT-, control without reverse transcriptase.
-catenin MO resulted in an expanded area of XXBP-1
expression.
Next, we investigated the neuralizing effect of neural
inducers such as noggin (Zimmerman et al., 1996) and Zic3
(Nakata et al., 1997) on the expression of XXBP-1 and
BMP-4 using the animal cap assay. Either noggin (160
pg/embryo) or Zic3 (160 pg/embryo) was injected into all
blastomeres of four-cell-stage embryos. Animal caps were
dissected at stage 9 and cultured until the sibling control
embryos reached stage 18. The expression of BMP-4,
XXBP-1, Xvent-1, and NCAM in the explants was analyzed
by RT-PCR (Fig. 3II). XXBP-1 and Xvent-1 were sup-
pressed by noggin as has also been previously shown for
BMP-4 (Gammill et al., 2000). Neural induction of ectoder-
mal explants induced by noggin and Zic3 was verified by
the upregulation of NCAM. Both XXBP-1 and BMP-4 were
downregulated by Zic3, but not to the same extent as with
noggin overexpression.
Overexpression of XXBP-1 causes ventralization
The area of XXBP-1 expression overlaps with that of
BMP-4 and suggests that XXBP-1 may play a role in dor-
soventral patterning during embryonic development. We
used a gain-of-function approach to test this hypothesis.
Embryos injected with XXBP-1 (0.2 ng mRNA/embryo)
into both dorsal blastomeres at the four-cell stage showed a
range of ventralized phenotypes (93%, 81/87 embryos; Fig.
4I), including dorsoanterior index (DAI) 2 to 4 (Kao and
Elinson, 1988). The most prominent abnormalities were the
suppression of dorsoanterior structures, including the ce-
ment gland, eyes, otic vesicles, and in many cases, the entire
head. A higher dose of XXBP-1 (0.4 ng mRNA/embryo)
caused the loss of head structures and axis defects, and was
scored as DAI 1 or 2 (100% ventralization, 99/99 embryos).
The highest dose of XXBP-1 (0.8 ng mRNA/embryo) in-
jected into either both dorsal or all four blastomeres of
four-cell-stage embryos resulted in a strong ventralization,
including the complete loss of all axial structures, and was
classified as DAI of 0 or 1 (93% ventralization with dorsal
injection, 38/41 embryos; 100% ventralization with radial
injection, 21/21 embryos). Representative phenotypes as
well as histological analysis of sections through these em-
bryos are shown in Fig. 4I. Compared with the normal
embryo (Fig. 4IF), sections from embryos overexpressing
XXBP-1 (Fig. 4IB) demonstrated reduction of the notochord
and an indiscernible brain or spinal cord (Fig. 4IG). The
notochord was either completely absent or severely reduced
in embryos injected with the highest amount of XXBP-1
RNA (data not shown). The effects of ventral XXBP-1
overexpression were dose-dependent, but much less pro-
nounced. Ventral injection of 0.2 ng XXBP-1 mRNA per
embryo resulted in 12.5% (7/56 embryos) normal, 14%
(8/56 embryos) ventralized embryos with a DAI 4-5 and
73% (41/56 embryos) embryos with posterior enlargement
(Fig. 5IID). The highest amount of XXBP-1 injected ven-
trally produced microcephaly in 100% of embryos (17/17
embryos).
Disruption of neural marker genes by overexpression of
XXBP-1
The expression pattern of XXBP-1 suggests its role as an
antagonist of neural induction; moreover, its expression was
upregulated by neural antagonists. Next, we asked whether
XXBP-1 inhibits neural markers. To address this issue, 200
pg XXBP-1 mRNA was coinjected with 100 pg -galacto-
sidase (LacZ) mRNA as a lineage tracer into a single dorsal
blastomere of four-cell-stage embryos. The injected em-
bryos were fixed and stained with X-gal at late neurula
stages (stage 18-19). Expression of XAG2 (cement gland
marker; Aberger et al., 1998), Otx2 (anterior neural marker;
Blitz et al., 1995), Rx2A (lens marker; Yoshitake et al.,
1999), En2 (marker for the mid/hindbrain boundary; Hem-
mati-Brivanlou et al., 1991), Krox20 (marker for the r3 and
r5; Bradley et al., 1993), Pax6 (neural marker; Hollemann et
al., 1998), and Sox3 (pan neural marker; Penzel et al., 1997)
was examined by using whole-mount in situ hybridization
(Fig. 4II) in those embryos exhibiting -galactosidase ac-
tivity on only one side of the neural plate region. The
overexpression of XXBP-1 resulted in the reduction of all
Fig. 3. Effects of neural inhibitors and neural inducers on XXBP-1 expres-
sion. (I) Neural inhibitors and -catenin morpholino expand the expression
territories of XXBP-1. Embryos were injected dorsally at the four-cell stage
with (A) 8 ng -catenin morpholino, (B) 1 ng BMP-4 mRNA, (C) 80 pg
Dlx3 or (F) 80 pg Msx1 mRNA, and were fixed at midgastrula stages for
whole-mount in situ hybridization with XXBP-1 antisense RNA. (D) Un-
injected embryos were UV irradiated at 302 nm for 45 s. The expression
area of XXBP-1 was expanded compared with control embryos (E). Whole-
mount in situ hybridization and fixation after staining were performed
identically for all embryos to eliminate differences due to overstaining. (II)
Gene expression in noggin or Zic3 animal caps. At stage 9, animal caps
were dissected from uninjected embryos (AC) or embryos injected into all
four blastomeres at the four cell stage with 160 pg Zic3 or 160 pg noggin
mRNA. The expression of BMP-4, XXBP-1, Xvent-1, and NCAM was
assayed by using RT-PCR from RNA isolated after sibling embryos
reached stage 18. ODC served as a loading control. Noggin suppressed
XXBP-1 and BMP-4 expression, but induced NCAM.
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neural markers analyzed: Otx2 (60%, 94/156 embryos),
Rx2A (41%, 47/116 embryos), En2 (49%, 31/63 embryos),
Krox20 (71%, 34/48 embryos), Pax6 (50%, 28/56 embry-
os), and Sox3 (58%, 44/76 embryos). These neural markers
were either expressed in a smaller area or the expression
level was reduced as seen by decreased staining intensity. In
contrast to the neural markers examined, no change of
XAG2 expression was observed after injection of the same
amount of XXBP-1 mRNA. The inhibition of neural mark-
ers suggests that XXBP-1 plays an instructive role in the
formation of epidermal tissue. It may act directly or by
inducing a secreted molecule, perhaps BMP itself. Alterna-
tively, the perturbation of the neural markers could be a
result of direct effects on the mesoderm. In some cases,
overexpression of XXBP-1 on only one side of the embryo
may also have caused improper morphogenetic movements,
including defects in gastrulation resulting from injury at the
injected side. It cannot be excluded that interference with
morphogenetic movements may also have led to the disrup-
tion of neural markers. To rule out this possibility, we
performed the XXBP-1 overexpression experiments de-
scribed below in animal caps.
Overexpression of XXBP-1 leads to ventralization of
dorsal mesoderm
XXBP-1 is expressed in the dorsal blastopore lip during
gastrulation (Fig. 2I), suggesting that it may interact with
genes affecting dorsoventral patterning during early embry-
onic development. We therefore studied the influence of
XXBP-1 on the dorsal mesodermal marker genes, Chordin
(Chd) and goosecoid (gsc), in the dorsal marginal zone
(DMZ) using whole-mount in situ hybridization. Embryos
were injected with XXBP-1 mRNA (0.1 ng/blastomere) dor-
sally into the equatorial region at the four-cell stage, and
Chd and gsc expression was visualized by using whole-
mount in situ hybridization at midgastrula (stages 11-11.5).
Overexpression of XXBP-1 led to the suppression of Chd
(65%, 37/57 embryos) and gsc (75%, 42/56 embryos), il-
lustated by their diminished staining in the dorsal blastopore
lip (Fig. 4III).
Further evidence for the ventralization of cell fate was
provided by RT-PCR analysis of the marker genes involved
in dorsoventral patterning. Dorsal marginal zone (DMZ)
explants were dissected from embryos radially injected with
either low (0.1 ng/blastomere) or high (0.4 ng/blastomere)
doses of XXBP-1 mRNA at four-cell stage. The relative
expression of various marker genes was examined by RT-
PCR in explants cultured until control embryos reached
stage 22 (Fig. 4IV). Gsc, a marker for head mesoderm in
tailbud embryos, was repressed strongly by XXBP-1. Like-
wise, Xnot, a marker for notochord, was also suppressed,
but to a lesser extent. These results indicate that the forma-
tion of both head mesoderm and notochord is suppressed by
XXBP-1. Otx2 was downregulated, confirming our in situ
hybridization results (Fig. 4IID). Decreased dorsal meso-
derm marker expression corresponded to increased ventro-
posterior mesodermal marker expression. A dose-dependent
upregulation of Xhox3, Xvent-1, and BMP-4 was induced by
ectopic XXBP-1. Taken together, overexpression of XXBP-1
in the dorsal marginal zone explants led to downregulation
of dorsal marker genes, and in parallel, upregulation of
ventral marker genes.
XBP-1 prevents neuralization of ectodermal explants
induced by disaggregation
XXBP-1 is upregulated by neural inhibitors (Fig. 3I) and
downregulated by neural inducers (Fig. 3II), suggesting that
it may be involved in epidermal differentiation. It was
previously shown that dissociation of ectodermal cells leads
to neuralization (Grunz and Tacke, 1989; Godsave and
Slack, 1991). We therefore performed a cell dissociation
assay to determine whether overexpression of XXBP-1
could inhibit neuralization of disaggregated ectodermal ex-
plants. As shown in Fig. 4VA, the disaggregated animal
caps (ectodermal cells) were shifted from an epidermal to a
neural fate as a result of disaggregation and subsequent
reaggreagation. In contrast to the intact animal caps, NCAM
was upregulated and maintained at a high level after re-
aggregation. Epidermal keratin was still detected because
the outer cell layer of the animal caps was included, which
remained partially undissociated. The expression of NCAM
was reduced and epidermal keratin was upregulated in ex-
plant cells overexpressing either XXBP-1 (0.4 ng/embryo)
or BMP-4 (0.8 ng/embryo) compared with cells from the
uninjected animal caps. Cell fate change occured in the
absence of mesoderm induction, since the mesodermal
markers Xbra and muscle actin were not expressed. Again,
these results suggest that XXBP-1 functions as a neural
inhibitor in Xenopus ectodermal explants.
It should be mentioned that there was a clear difference in
the ability to form reaggregates between normal cells and
XXBP-1 overexpressing cells. Large numbers of cells from
XXBP-1-injected animal caps did not reaggregate (Fig. 4VD).
This was in contrast to control and BMP-4-overexpressing
ectodermal cells, which readily formed three-dimensional ag-
gregates (Fig. 4VB and C). These observations indicate that
cell adhesion is severely impaired by XXBP-1 overexpression.
Only reaggregated cells (indicated by arrow in Fig. 4VD) were
harvested for RT-PCR analysis in these experiments.
XXBP-1 reverses dorsalization induced by dominant
negative BMP receptor
Both XXBP-1 and BMP-4 are excluded from the prospec-
tive neural plate during gastrulation and neurulation based
on their expression patterns. Gain-of-function experiments
revealed that both XXBP-1 and BMP-4 induced embryo
ventralization. Moreover, XXBP-1, like BMP-4, inhibited
neuralization of ectodermal explants induced by disaggre-
gation. These similarities imply that the two factors may act
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in a common pathway. We tested the relationship between
XXBP-1 and the BMP signaling pathway using the animal
cap assay and a gain-of-function assay. Either XXBP-1 (0.4
ng XXBP-1 mRNA/embryo), the truncated BMP receptor
type I (1.6 ng tBMPRI mRNA/embryo; Suzuki et al., 1994),
or a combination of both (1.6 ng tBMPRI and 0.4 ng
XXBP-1 mRNA/embryo) was injected into the animal half
of each blastomere of the four-cell-stage embryo. Animal
caps were dissected from these embryos, and marker gene
expression was examined by using RT-PCR analysis (Fig.
5I). The epidermal marker, epidermal keratin, was ex-
pressed at the same level in both control and XXBP-1-
overexpressing animal caps. In line with previously pub-
lished data (Suzuki et al., 1994; Sasai et al., 1995), ectopic
expression of tBMPRI in ectodermal explants resulted in
neural induction, revealed by a strong increase in the ex-
pression of the neural markers, Otx2 and NCAM, and de-
creased expression of epidermal keratin. The expression of
epidermal keratin was partially restored accompanied by
decreased Otx2 and NCAM expression after tBMPRI and
XXBP-1 coinjection. Taken together, the ectodermal cell
responded to the combination of tBMPRI and XXBP-1 by
adopting a cell fate inclined to epidermis in contrast to the
neural fate induced by tBMPRI alone. XXBP-1 attenuated
neural induction by tBMPRI in the animal cap assay. Thus,
XXBP-1 is likely to be downstream of the BMP receptor.
Gain-of-function experiments also support XXBP-1 ac-
tion to be downstream of the BMP receptor. Either tBMPRI
or XXBP-1 alone or both tBMPRI and XXBP-1 were injected
ventrally or radially into four-cell-stage embryos. Ectopic
tBMPRI (1.6 ng mRNA per embryo) led to the formation of
a secondary embryonic axis when injected ventrally (43%,
23/53 embryos; Fig. 5IIB), and caused dorsalization, indi-
cated by the enlargement of anterior structures, when in-
jected radially (100%, 27/27 embryos; Fig. 5IIE). The dor-
salized phenotype was efficiently reversed by coinjection
with XXBP-1. Embryos coinjected ventrally with mRNA for
both XXBP-1 and tBMPRI (0.2 ng XXBP-1 mRNA and 1.6
ng tBMPRI mRNA per embryo) (Fig. 5IIC) exhibited sim-
ilar phenotypes to embryos ventrally injected with XXBP-1
mRNA alone (0.2 ng mRNA per embryo; Fig. 5IID).
XXBP-1 and tBMPRI coinjected embryos (94.3%, 82/87
embryos) showed a slight repression of anterior axis with a
significant posterior enlargement. Additionally, the embryos
coinjected radially with XXBP-1 and tBMPRI (0.4 ng
XXBP-1 mRNA and 1.6 ng tBMPRI mRNA per embryo)
showed a range of ventralized phenotypes signified by the
reduced anterior structures (92%, 11/12 embryos; Fig. 5IIF
and G). In summary, these data support the hypothesis that
XXBP-1 is a component of the BMP signaling pathway and
acts downstream of the BMP receptor.
XXBP-1 may act as a transcriptional activator
Sequence comparison showed that XXBP-1 is a basic
leucine zipper transcription factor. This gives rise to the
question whether XXBP-1 acts as an activator or repressor
of transcription. We synthesized three repressor and activa-
tor constructs by fusion of the putative DNA-binding do-
main of XXBP-1 to the previously characterized sequences
encoding the activator or repressor domains of known tran-
scription factors. XXBP1-EnR was fused with the repressor
domain from Drosophila engrailed (Jaynes and O’Farrell,
1991), XXBP1-Eve with the repressor domain of even-
skipped (Han and Manley, 1993), and XXBP1-VP16 with
the activator domain of VP16 (Friedman et al., 1988). A
schematic diagram of wild-type XXBP-1 and the fusion
constructs is shown in Fig. 6I. Theoretically, the fusion
constructs should completely or, at least partially, mimic
wild-type XXBP-1 in the overexpression experiments if they
have similar actions on transcription as XXBP-1. Moreover,
as XXBP-1 could mediate BMP signaling, it was expected
that the loss of XXBP-1 function might lead to neural in-
duction in animal cap assays or formation of a secondary
embryonic axis in overexpression experiments. In addition,
based on the expectation that truncated XXBP-1 may se-
quester wild-type XXBP-1 and interfere with dimerization,
a truncated XXBP-1 construct containing the sequence en-
coding the basic leucine zipper domain was also created.
Overexpression of high doses of fusion constructs caused
apoptosis. The dosages were, therefore, adjusted to avoid
this phenotype. Embryos microinjected ventrally with the
same dose (0.16 ng mRNA/embryo) of either XXBP1-EnR
or truncated XXBP-1 showed spina bifida or a bent axis.
Unexpectedly, microinjection of XXBP1-VP16 (0.04 ng
mRNA/embryo) produced posterior axis enlargement (96%,
70/73 embryos), a phenotype similar to that of wild-type
XXBP-1, although the reason for this is unclear. Ventral
overexpression of XXBP1-Eve (0.16 ng mRNA/embryo)
produced a secondary axis in 10% of the embryos or pri-
marily gastrulation defects giving rise to spina bifida (81%,
79/98 embryos) (Fig. 6IIA–F).
Embryos microinjected dorsally with the same amount of
mRNA (0.16 ng mRNA/embryo) of XXBP1-Eve, XXBP1-
EnR, or truncated XXBP-1 showed either gastrulation de-
fects leading to spina bifida or the loss of anterior structures,
which could have also been due to interference with mor-
phogenetic movements. Embryos ectopically overexpress-
ing XXBP1-VP16 (0.04 ng mRNA/embryos) dorsally exhib-
ited either the loss of dorsoanterior structures (46%, 23/50
embryos; Fig. 6IIG) as with overexpression of wild-type
XXBP-1 or exogastrulation (54%, 27/50 embryo; Fig. 6IIH).
If XXBP-1 is a transcriptional activator, the chimeric
protein containing the VP16 activator domain should have
similar effects to that of XXBP-1. Thus, the XXBP1-Eve
construct would function as a dominant negative mutant and
would induce neural markers, such as NCAM in contrast to
wild-type XXBP-1 in the animal cap assay. Ectodermal
explants were dissected from the embryos injected with one
of the various constructs or wild-type XXBP-1, and were
cultured until control embryos reached stage 27. The rela-
tive expression level of XAG1, Otx2, NCAM, nrp-1, Msx1,
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Fig. 4. Biological activity of XXBP-1 (I)Phenotypes of XXBP-1-injected embryos. (A–C) Examples of ventralized phenotypes after dorsal injection of 200 pg
XXBP-1 mRNA at the four cell stage. (D, E) The ventralized embryos exhibited no anteroposterior or dorsoventral axes, after either dorsal injection of 400 pg XXBP-1
mRNA or radial injection of 800 pg XXBP-1 mRNA. (F–G) A transverse section through the embryo injected dorsally with 200 pg XXBP-1 mRNA shows a reduced
notochord (nt) and an indiscernible spinal cord (sc) as compared with the control embryo (F). pn, pronephros; sm, somite. (II) Disruption of neural marker genes
in vivo by XXBP-1. A single dorsal blastomere was coinjected with 200 pg XXBP-1 and 100 pg LacZ mRNA at the four cell stage. The embryos were fixed at the
late neurula stages and stained for lacZ to identify the injected side, and whole-mount in situ hybridization with antisense probes for the cement gland marker, XAG2,
and neural marker genes was carried out. (A–N) The expression pattern in control embryos is shown at the left, and expression after XXBP-1 overexpression on one
side is shown at the right. (A–B) XAG2 expression was not changed by XXBP-1 overexpression at this dose. (C–N) XXBP-1 overexpression inhibited the expression
of Otx2 (anterior neural marker), Rx2A (lens marker), En2 (marker for the mid/hindbrain boundary), Krox20 (marker for r3 and r5), Pax6 (neural marker), and Sox3
(pan-neural marker). (O, P) Embryos injected only with lacZ mRNA as a control showed no changes in En2 or Sox3 expression. (III) Overexpression of XXBP-1
downregulates the dorsal mesoderm markers, Chordin and goosecoid. Embryos were injected dorsally into the marginal zone with 0.1 ng/blastomere of XXBP-1
mRNA at the four cell stage and fixed at midgastrula for whole-mount in situ hybridization with Chd and gsc antisense RNA. (A, C) Expression in control embryos.
(B, D) XXBP-1 overexpression reduced both Chd and gsc expression. (IV) Overexpression of XXBP-1 leads to ventralization of dorsal mesoderm. Dorsal and ventral
marker genes were analyzed by using RT-PCR in whole embryos (st. 22 embryo), dorsal or ventral marginal zone explants (DMZ or VMZ, respectively) from
uninjected embryos, or embryos radially injected with 0.1 or 0.4 ng XXBP-1 mRNA per blastomere at the four-cell stage. Marginal zones were explanted at the start
of gastrulation and cultured until sibling embryos reached stage 22. ODC served as a loading control. RT, control without reverse transcriptase. (V) XXBP-1 inhibits
neural induction in dissociated ectodermal explants. Animal caps were dissected from uninjected embryos (AC) and embryos injected with either 0.4 ng XXBP-1
or 0.8 ng BMP-4 mRNA into all four blastomeres at the four cell stage. The ectodermal cells from the animal caps were dissociated then allowed to reassociate and
cultured subsequently for 24 h. (A) RT-PCR was used to analyze the expression of the neural marker, NCAM; ectodermal marker, epidermal keratin (EK); and
mesoderm markers, actin and Xbra. BMP-4 was injected as a positive control for inhibition of neural induction. ODC was employed as a loading control. (B–D)
At 24 h after reaggregation, the ectodermal cells from XXBP-1 animal caps were not able to reaggregate as well as cells from control or BMP-4 animal caps. The
majority of XXBP-1-overexpressing ectodermal cells did not reaggregate. Only reaggregated cells (indicated by arrow) were harvested for RT-PCR analysis. RT,
control without reverse transcriptase.
Fig. 5. XXBP-1 may be involved in the BMP signaling pathway. (I) XXBP-1 overexpression reduces neural induction by tBMPRI. At stage 9, animal caps
were dissected from uninjected control embryos (AC) or embryos injected with either 0.4 ng XXBP-1, 1.6 ng tBMPRI, or 1.6 ng tBMPRI  0.4 ng XXBP-1
mRNA into all blastomeres at the four-cell stage, and were cultured until sibling embryos reached stage 28. Neural and epidermal marker genes were analyzed
by using RT-PCR with RNA from animal caps or intact embryos (st. 28 embryo). Overexpression of XXBP-1 attenuated the neural induction by tBMPRI.
EK, epidermal keratin; RT, control without reverse transcriptase. (II) Microinjection of XXBP-1 reverses tBMPRI-induced dorsalization. Phenotypes were
examined after overexpression of either XXBP-1, tBMPRI, or both. (B) A secondary axis was induced by injection with 1.6 ng tBMPRI mRNA ventrally at
the four cell stage. (C) Coinjection of 1.6 ng tBMPRI and 0.2 ng XXBP-1 mRNA ventrally at the four cell stage reversed formation of the secondary axis
and caused posterior enlargement like injection of 0.2 ng XXBP-1 mRNA alone (D). Phenotypes of embryos microinjected into four blastomeres at the four
cell stage were shown in (E–G). Two cement glands (arrows) were induced by tBMPRI alone (1.6 ng of tBMPRI mRNA) (E), but coinjection with XXBP-1
mRNA (1.6 ng tBMPRI and 0.4 ng of XXBP-1) reversed embryo dorsalization (F, G).
Fig. 6. Overexpression of fusion constructs and truncated XXBP-1. (I) Fusion and truncated XXBP-1 constructed. The amino terminal sequence (amino acids
1–126) of XXBP-1, containing the basic leucine zipper DNA binding domain (bZIP), was used to create several fusion constructs (white box). The remaining
XXBP-1 sequence (amino acids 127–350) is indicated by the vertically lined box and was replaced by the VP16 activation domain (shaded, slashed box) to
form XXBP1-VP16, or by the even-skipped repressor domain (shaded box) to form XXBP1-Eve. The amino terminal fragment of XXBP-1 was also subcloned
into pCS2MTEnR, containing the sequence encoding the engrailed repression domain (shaded, hatched box) and the Myc-tag (slashed box) to obtain
XXBP1-EnR. Truncated XXBP-1 encodes the amino acids 1–126. (II) Phenotypes of embryos injected with fusion constructs. (A, D) Ventral injection with
either 0.16 ng XXBP1-EnR mRNA or 0.16 ng truncated XXBP-1 mRNA produced embryos with spina bifida. (B, C) Ventral injection with 0.16 ng
XXBP1-Eve mRNA show either a secondary axis (B) or spina bifida (C). (E, F) Ventral injection of either 0.04 ng XXBP1-VP16 mRNA or 0.2 ng wild-type
XXBP-1 mRNA, respectively, resulted in posterior enlargement. (G, H) Dorsal injection (Dor) of the same amount of XXBP1-VP16 caused either loss of
dorsoanterior structures (G) or exogastulation (H). Note that XXBP1-Eve is able to induce a secondary axis in embryos, but ventral injection with
XXBP1-VP16 induces a similar phenotype to that of wild-type XXBP-1, suggesting that XXBP-1 may be an activator of transcription. (III) Expression of fusion
constructs in animal caps indicate XXBP-1 may be an activator of transcription. Animal caps were dissected from uninjected embryos (AC) or embryos
injected with 0.08 ng XXBP1-VP16, 0.64 or 0.32 ng XXBP1-Eve, 0.32 ng truncated XXBP-1, 0.32 ng XXBP1-EnR, 1.6 ng tBMPRI or 0.32 ng XXBP-1 mRNA,
and cultured until sibling embryos reached stage 27. RT-PCR was used to measure the expression of the marker genes, XAG1, Otx2, NCAM, nrp-1, Msx1,
and Epidermal Keratin (EK) in RNA from animal caps or whole embryos (st. 27 embryo). The neural marker genes, NCAM and nrp-1, were induced by
XXBP1-Eve, but not by XXBP1-VP16 or wild-type XXBP-1, suggesting that XXBP-1 functions as a transcription activator. ODC was employed as a loading
control. RT, control without reverse transcriptase.
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and epidermal keratin was investigated by using RT-PCR
(Fig. 6III). As expected, XXBP1-Eve induced the neural
markers, NCAM, nrp-1, and Otx2, in a dose-dependent man-
ner. Overexpression of truncated XXBP-1 resulted in a mi-
nor induction of the neural markers, and Otx2 could be
slightly induced by XXBP1-EnR. In contrast, the epidermal
marker, Msx1, was moderately downregulated by XXBP1-
Eve, truncated XXBP-1, XXBP1-EnR, and tBMPRI. The
expression of epidermal keratin was also reduced in
XXBP1-Eve-injected ectodermal explants. Injection of ei-
ther XXBP1-VP16 or wild-type XXBP-1 produced similar
results with the exception that XXBP1-VP16 slightly up-
regulated XAG1. These data support the view that XXBP-1
may function as a transcriptional activator during the em-
bryonic development.
Discussion
In this study, we describe a novel leucine zipper tran-
scription factor, XXBP-1, which is expressed in the ventral
ectoderm and dorsal blastopore lip of the Xenopus gastrula.
XXBP-1 causes embryo ventralization and may function as
an activator downstream of the BMP receptor in the signal-
ing pathway.
Differentially restricted pattern of XXBP-1 expression in
Xenopus embryos
The expression pattern of XXBP-1 suggests a function as
a negative regulator of neural induction. The results from
microinjection experiments and animal cap assays presented
in this paper support this view. The fact that XXBP-1 is
expressed in the dorsal blastopore lip but induces embryo
ventralization is reminiscent of ADMP (anti-dorsalization
morphogenetic protein; Moos et al., 1995). In light of the
classical view, both XXBP-1 and ADMP are unexpected
genes expressed in the Spemann–Mangold organizer area
since it was primarily thought of as only the source of
dorsalizing signals. The classical genes expressed in the
Spemann–Mangold organizer generally act as neuralizing or
dorsalizing factors, and induce neutralization and a second-
ary axis when ectopically expressed. However, overexpres-
sion of either XXBP-1 or ADMP caused suppression of
dorsal and anterior structures as well as the neural marker,
NCAM. Additionally, XXBP-1 suppressed gsc and Chd, and
upregulated BMP-4, Xvent-1, and Xhox3, playing an in-
structive role in epidermal induction. These pieces of evi-
dence support the view that local negative regulatory mech-
anisms may exist in the Spemann–Mangold organizer to
restrain the classical neuralization and dorsalizing activity.
The dorsalizing and neuralizing activity as well as negative
regulatory mechanisms are simultaneously required in the
organizer for the establishment of a precise spatial control in
the organizer to direct appropriate execution of complex
biological processes during embryonic development. The
fact that ADMP is not inhibited by noggin in contrast to
XXBP-1 (Dosch and Niehrs, 2000) suggests that both genes
may function through distinct pathways. The expression of
XXBP-1, being excluded from the prospective neural plate
of the gastrula, and located maximally in the cement gland
primordium of the neurula, is similar to that of BMP-4
(Fainsod et al., 1994; Hemmati-Brivanlou and Thomsen,
1995; Gammill et al., 2000), indicating that XXBP-1 may be
involved in BMP signaling. The expression of Xlim-1 and of
XXBP-1 overlaps in the Spemann–Mangold organizer at
gastrula stages and in the pronephros at tailbud stages;
however, it remains to be shown if an interaction between
Xlim-1 (Taira et al., 1994) and XXBP-1 exists.
XXBP-1 may act downstream of the BMP receptor and
up-regulate BMP-4 expression
The BMP signaling pathway is implicated in both meso-
derm induction and dorsoventral pattering. The binding to
BMP-4 by organizer-secreted antagonists such as Chordin,
Noggin, Follistatin, and Cerberus is thought to be respon-
sible for the establishment of a morphogen gradient of
BMP-4 activity, which specifies different dorsoventral fates
in early gastrulae (for reviews, see Dale and Jones, 1999; De
Robertis et al., 2000). The experiments presented here pro-
vide evidence supporting the hypothesis that XXBP-1 is
involved in the BMP pathway. Firstly, the expression pat-
tern of XXBP-1 at the gastrula stage indicates that it may
play a negative role in neural induction. In the neurula,
XXBP-1 is intensely expressed in the cement gland primor-
dium, as is BMP-4. Secondly, ectopic expression of BMP-4
upregulated XXBP-1 expression in the dorsal marginal zone
and vice versa. Thirdly, the overexpression of either
XXBP-1 or BMP-4 ventralized the embryo in a dose-depen-
dent manner, resulting in phenotypes ranging from micro-
cephaly to belly pieces. Fourthly, both BMP-4 and XXBP-1
suppressed gsc in DMZ explants and were downregulated
by noggin in the animal cap assay. Fifthly, XXBP-1 like
BMP-4, inhibited neural induction in dissociated ectoder-
mal cells. Finally, coinjection of XXBP-1 with tBMPRI
reversed the dorsalization induced by tBMPRI alone, and
directed a proepidermal cell fate in the animal cap assay.
Our results support the hypothesis that XXBP-1 acts
downstream of the BMP receptor. Coinjection of XXBP-1
and tBMPRI caused suppression of the neural markers,
NCAM and Otx2, and the partial restoration of epidermal
keratin expression, reverting the effects of tBMPRI alone.
These results indicate that the ectoderm adopted a more
epidermal cell fate, and that XXBP-1 was sufficient to at-
tenuate neuralization induced by tBMPRI. Moreover, the
dorsalization and formation of a secondary axis after injec-
tion of tBMPRI was also reversed by XXBP-1 coinjection,
suggesting that XXBP-1 acts downstream of the BMP re-
ceptor. Furthermore, BMP-4 was induced in the DMZ by
XXBP-1, which may indicate that XXBP-1 is required for
the maintenance of BMP-4 expression.
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Sequence analysis identified XXBP-1 as a basic leucine
zipper transcription factor. This class of transcription factors
acts as both activators and repressors of transcription. One
strategy to characterize whether a given transcription factor
acts as an activator or repressor in a certain system is to
construct a dominant-negative mutant (Conlon et al., 1996;
Horb and Thomsen, 1997; Onichtchouk et al., 1998; Go´-
mez-Skarmeta et al., 2001). Using this approach, XXBP-1
showed activity suggestive of an activator during BMP
signaling by several criteria. When fused with the activator
domain of VP16, the XXBP1-VP16 showed similar biolog-
ical activities to wild-type XXBP-1. Both wild-type
XXBP-1 and XXBP1-VP16 injected on the ventral side
caused a posterior enlargement of the larval tail area only. In
the animal cap assay, both XXBP1-VP16 and XXBP-1 did
not induce neural markers. In contrast, when fused with the
repressor domain of Eve, the XXBP1-Eve was able to induce
a secondary axis when ventrally overexpressed at least in
some cases. Moreover, XXBP1-Eve induced the neural
markers, NCAM and nrp-1, and downregulated Msx1 and
epidermal keratin in the animal cap assay. Thus, XXBP1-
Eve upregulates genes that would ordinarily be repressed by
XXBP-1, supporting that XXBP1-Eve functions as the dom-
inant negative mutant of XXBP-1. Another repressor con-
struct, XXBP1-EnR, did not induce pan-neural markers, or a
secondary axis, but caused defects in gastrulation. This
conflicting result may be explained by the interference of
the myc-tag, directly N-terminal to the XXBP-1 bZIP do-
main, with DNA binding activity of this fusion construct. It
should be mentioned that gastrulation defects were observed
in some of the embryos after the overexpression of each
construct, which can be interpreted in light of their mech-
anism of action. A strong transcriptional activator or repres-
sor domain will be active wherever there is an accessible
XXBP-1 binding site, and not only in cells expressing
XXBP-1. Furthermore, the activity of the constructs is not
developmentally regulated during embryonic development.
This uncoupling from developmental regulation will inevi-
tably lead to pleiotropic effects during embryonic develop-
ment. The truncated XXBP-1 had a weak effect on neural
induction indicated by slightly increased Otx2 and NCAM
expression and caused gastrulation defects giving rise to
spina bifida. This suggests that XXBP-1 may form ho-
modimers to carry out its function.
XXBP-1 interacts with the -catenin/Wnt pathway
In Xenopus, the organizer formation requires both
TGF- and -catenin signaling (Harland and Gerhart, 1997;
Heasman, 1997; Niehrs, 1999, 2000). Signals originating
from the organizer are involved in further patterning along
both the anteroposterior and dorsoventral axes and in the
induction of the central nervous system of the embryo.
However, several pieces of evidence suggest that ectoderm
on the dorsal side is predisposed to become neural in con-
trast to ventral ectoderm (London et al., 1988; Sokol and
Melton, 1991; Kuo et al., 1998). Several lines of evidence
indicate that -catenin/Wnt signaling participates in this
process as well as later in neural plate pattern formation
(Wylie et al., 1996; McGrew et al., 1995). The repression of
BMP-4 in the dorsal mesoderm and prospective neural plate
is mediated by -catenin/Wnt signaling during gastrulation
(Baker et al., 1999). Moreover, -catenin activates the early
expression of secreted BMP antagonists, such as Chordin,
in a preorganizer region at the dorsal side of the Xenopus
blastula (Wessely et al., 2001). In this study, we showed that
the expression of XXBP-1 was expanded over the entire
DMZ in embryos in which -catenin/Wnt signaling was
blocked by -catenin MO. This phenotype was mimicked
by dorsal overexpression of BMP-4 and UV treatment.
These results offer further evidence for the existence of
crosstalk between BMP and -catenin/Wnt signaling. An-
other group has also reported evidence to support crosstalk
between -catenin/Wnt signaling and Dlx3, another BMP
target gene. It was shown that the repression of Dlx3 is
mediated by signaling via -catenin, but is probably not
dependent on the induction of the Xnr3 or Chordin by
-catenin (Beanan et al., 2000).
Taken together, our data support a view that XXBP-1
acts downstream of the BMP receptor. Additionally,
XXBP-1 negatively regulates the dorsalizing and neuralizing
activities of the Spemann–Mangold organizer, and may
mediate BMP signaling during epidermal induction and
inhibition of neural differentiation.
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